For example, increased intake of SCFAs was proven to be beneficial in the treatment of colitis (Harig et al., 1989), and the anti-inflammation effect might be mediated by G-protein coupled receptor 43 (Maslowski et al., 2009). Here, FFAR2 is linked to colitis.